Moreno-Nieves, U. Y., Didier, C., Lévy, Y., Barré-Sinoussi, F., & Scott-Algara, D. (2015). S100A9 Tetramers, Which are Ligands of CD85j, Increase the Ability of MVA(HIV)-Primed NK Cells to Control HIV Infection. Front Immunol.

Moreno-Nieves, Uriel Y., Céline Didier, Yves Lévy, Françoise Barré-Sinoussi, and Daniel Scott-Algara. "S100A9 Tetramers, Which Are Ligands of CD85j, Increase the Ability of MVA(HIV)-Primed NK Cells to Control HIV Infection." Front Immunol 2015.

Moreno-Nieves, Uriel Y., et al. "S100A9 Tetramers, Which Are Ligands of CD85j, Increase the Ability of MVA(HIV)-Primed NK Cells to Control HIV Infection." Front Immunol 2015.